Breast Cancer Version 2.2015
William J. Gradishar(Northwestern University), Rashmi Kumar(University of London), Matthew P. Goetz(Mayo Clinic), George Somlo(City Of Hope National Medical Center), Sharon H. Giordano(The University of Texas MD Anderson Cancer Center), Mary Lou Smith(Research Advocacy Network), Beryl McCormick(Memorial Sloan Kettering Cancer Center), Lori J. Pierce(University of Michigan–Ann Arbor), Sameer A. Patel, Meena S. Moran(Cleveland Clinic), Andres Forero(University of Alabama at Birmingham), Clifford A. Hudis(American Society of Clinical Oncology), Lori J. Goldstein(Shaanxi Research Association for Women and Family), Melinda L. Telli(Stanford University), Harold J. Burstein(Dana-Farber Cancer Institute), Sarah L. Blair(University of California San Diego), Benjamin O. Anderson(University of Washington), Elizabeth Reed(Cancer Institute (WIA)), Ingrid A. Mayer(Vanderbilt University), Lee S. Schwartzberg(Renown Health), Ronald Balassanian, Karen L. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dorothy A. Shead(University of the Witwatersrand), Kilian Salerno(Cleveland Clinic), Hatem Soliman(Moffitt Cancer Center), Anthony Elias(University of Colorado Cancer Center), John H. Ward(Unknown), William B. Farrar, Steven J. Isakoff(Harvard University), Amy Cyr, P. Kelly Marcom(Duke University)
Cited by 183
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
|Science|2013|2.5k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k